Tocilizumab in Children With ACP
Tocilizumab in Children With ACP
Active, not recruiting · NCT03970226 · Registry updated 2026-02-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tocilizumab in Children With ACP | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adamantinous craniopharyngioma, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Early phase 1 | 2026-02-17 | NCT03970226 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| National Institutes of Health (NIH) | 667 |
| University of Colorado, Denver | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Colorado | Aurora | United States | 312 |